Benjamin L. Palleiko - CHIEF EXECUTIVE OFFICER, Director at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Stock Symbol
KALV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Benjamin L. Palleiko - trading volume in the past year for KalVista Pharmaceuticals, Inc.

Holdings reported by Benjamin L. Palleiko for KalVista Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 404K $5.85M $14.48 Nov 18, 2025 Direct
Restricted Stock Unit 0 $1.88M $10.02 Nov 17, 2025 Direct Common Stock
Performance Stock Units 0 $0 $9.26 Nov 17, 2024 Direct Common Stock
Employee Stock Option 114K Aug 11, 2025 Direct Common Stock

Transactions reported by Benjamin L. Palleiko for KalVista Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.